Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with Talaromyces marneffei Infections

References

• Barcenas-Morales G, Cortes-Acevedo P, Doffinger R. Anticytokine autoantibodies leading to infection: early recognition, diagnosis and treatment options. Curr Opin Infect Dis. 2019;32(4):330–336. doi:10.1097/QCO.0000000000000561
   Web of Science ®Google Scholar
• Ku CL, Chi CY, von Bernuth H, Doffinger R. Autoantibodies against cytokines: phenocopies of primary immunodeficiencies? Hum Genet. 2020;139(6–7):783–794. doi:10.1007/s00439-020-02180-0
   PubMed Web of Science ®Google Scholar
• Browne SK. Anticytokine autoantibody-associated immunodeficiency. Annu Rev Immunol. 2014;32:635–657. doi:10.1146/annurev-immunol-032713-120222
   PubMed Web of Science ®Google Scholar
• Shih HP, Ding JY, Yeh CF, Chi CY, Ku CL. Anti-interferon-gamma autoantibody-associated immunodeficiency. Curr Opin Immunol. 2021;72:206–214. doi:10.1016/j.coi.2021.05.007
   Web of Science ®Google Scholar
• Cao C, Xi L, Chaturvedi V. Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen. Mycopathologia. 2019;184(6):709–720. doi:10.1007/s11046-019-00410-2
   PubMed Web of Science ®Google Scholar
• Vanittanakom N, Cooper CR, Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev. 2006;19(1):95–110. doi:10.1128/CMR.19.1.95-110.2006
   PubMed Web of Science ®Google Scholar
• Chan JF, Lau SK, Yuen KY, Woo PC. Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016;5:e19. doi:10.1038/emi.2016.18
   PubMed Web of Science ®Google Scholar
• Tang BS, Chan JF, Chen M, et al. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol. 2010;17(7):1132–1138. doi:10.1128/CVI.00053-10
   PubMedGoogle Scholar
• Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725–734. doi:10.1056/NEJMoa1111160
   PubMed Web of Science ®Google Scholar
• Zeng W, Qiu Y, Tang S, Zhang J, Pan M, Zhong X. Characterization of Anti–Interferon-γ Antibodies in HIV-Negative Patients Infected With Disseminated Talaromyces marneffei and Cryptococcosis. Open Forum Infect Dis. 2019;6(10):ofz208. doi:10.1093/ofid/ofz208
   Web of Science ®Google Scholar
• Guo J, Ning X-Q, Ding J-Y, et al. Anti–IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections. J Exp Med. 2020;217(12):12. doi:10.1084/jem.20190502
   Web of Science ®Google Scholar
• Chen ZM, Li ZT, Li SQ, et al. Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-gamma immunodeficiency: a prospective cohort study. BMC Infect Dis. 2021;21(1):587. doi:10.1186/s12879-021-06255-9
   Web of Science ®Google Scholar
• Pithukpakorn M, Roothumnong E, Angkasekwinai N, et al. HLA-DRB1 and HLA-DQB1 Are Associated with Adult-Onset Immunodeficiency with Acquired Anti-Interferon-Gamma Autoantibodies. PLoS One. 2015;10(5):e0128481. doi:10.1371/journal.pone.0128481
   Web of Science ®Google Scholar
• Ku CL, Lin CH, Chang SW, et al. Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia. J Allergy Clin Immunol. 2016;137(3):945–948e948. doi:10.1016/j.jaci.2015.09.018
   Web of Science ®Google Scholar
• Lin CH, Chi CY, Shih HP, et al. Identification of a major epitope by anti-interferon-gamma autoantibodies in patients with mycobacterial disease. Nat Med. 2016;22(9):994–1001. doi:10.1038/nm.4158
   Web of Science ®Google Scholar
• Kak G, Raza M, Tiwari BK. Interferon-gamma (IFN-gamma): exploring its implications in infectious diseases. Biomol Concepts. 2018;9(1):64–79. doi:10.1515/bmc-2018-0007
   PubMedGoogle Scholar
• Bartemes KR, Kita H. Innate and adaptive immune responses to fungi in the airway. J Allergy Clin Immunol. 2018;142(2):353–363. doi:10.1016/j.jaci.2018.06.015
   PubMed Web of Science ®Google Scholar
• Verma A, Wuthrich M, Deepe G, Klein B. Adaptive immunity to fungi. Cold Spring Harb Perspect Med. 2014;5(3):a019612. doi:10.1101/cshperspect.a019612
   PubMed Web of Science ®Google Scholar
• Jansen JM, Gerlach T, Elbahesh H, Rimmelzwaan GF, Saletti G. Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. J Clin Virol. 2019;119:44–52. doi:10.1016/j.jcv.2019.08.009
   PubMed Web of Science ®Google Scholar
• Auladell M, Jia X, Hensen L, et al. Recalling the Future: immunological Memory Toward Unpredictable Influenza Viruses. Front Immunol. 2019;10:1400. doi:10.3389/fimmu.2019.01400
   PubMed Web of Science ®Google Scholar
• Patel SY, Doffinger R, Barcenas-Morales G, Kumararatne DS. Genetically determined susceptibility to mycobacterial infection. J Clin Pathol. 2008;61(9):1006–1012. doi:10.1136/jcp.2007.051201
   Web of Science ®Google Scholar
• Sancho-Shimizu V, Perez de Diego R, Jouanguy E, Zhang SY, Casanova JL. Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol. 2011;1(6):487–496. doi:10.1016/j.coviro.2011.10.016
   PubMed Web of Science ®Google Scholar
• Supparatpinyo K, Khamwan C, Baosoung V, Sirisanthana T, Nelson KE. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet. 1994;344(8915):110–113. doi:10.1016/s0140-6736(94)
   PubMed Web of Science ®Google Scholar
• Paules C, Subbarao K. Influenza. Lancet. 2017;390(10095):697–708. doi:10.1016/s0140-6736(17)
   PubMed Web of Science ®Google Scholar
• Del Campo J, Bouley J, Chevandier M, et al. OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza. Front Immunol. 2021;12:678483. doi:10.3389/fimmu.2021.678483
   Web of Science ®Google Scholar
• Nussing S, Sant S, Koutsakos M, Subbarao K, Nguyen THO, Kedzierska K. Innate and adaptive T cells in influenza disease. Front Med. 2018;12(1):34–47. doi:10.1007/s11684-017-0606-8
   PubMed Web of Science ®Google Scholar
• Ostler T, Davidson W, Ehl S. Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma. Eur J Immunol. 2002;32(8):2117–2123. doi:10.1002/1521-4141(200208)32:8<2117::
   Web of Science ®Google Scholar
• Hufford MM, Kim TS, Sun J, Braciale TJ. Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med. 2011;208(1):167–180. doi:10.1084/jem.20101850
   Web of Science ®Google Scholar
• Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11(4):275–288. doi:10.1038/nri2939
   PubMed Web of Science ®Google Scholar
• Li Z, Lu G, Meng G. Pathogenic Fungal Infection in the Lung. Front Immunol. 2019;10:1524. doi:10.3389/fimmu.2019.01524
   PubMed Web of Science ®Google Scholar
• Holland SM, Dorman SE, Kwon A, et al. Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J Infect Dis. 1998;178(4):1095–1104. doi:10.1086/515670
   Web of Science ®Google Scholar
• Losana G, Rigamonti L, Borghi I, et al. Requirement for both IL-12 and IFN-γ signaling pathways in optimal IFN-γ production by human T cells. Eur J Immunol. 2002;32:3. doi:10.1002/1521-4141(200203)32:3<693::
   Web of Science ®Google Scholar
• Doffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38(1):e10–14. doi:10.1086/380453
   Web of Science ®Google Scholar
• Saraiva M, O’Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10(3):170–181. doi:10.1038/nri2711
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991;174(4):915–924. doi:10.1084/jem.174.4.915
   PubMed Web of Science ®Google Scholar
• Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev. 2005;203:38–47. doi:10.1111/j.0105-2896.2005.00227.x
   PubMed Web of Science ®Google Scholar
• Olbrich P, Freeman AF. STAT1 and STAT3 mutations: important lessons for clinical immunologists. Expert Rev Clin Immunol. 2018;14(12):1029–1041. doi:10.1080/1744666X.2018.1531704
   PubMed Web of Science ®Google Scholar
• Filipe-Santos O, Bustamante J, Chapgier A, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006;18(6):347–361. doi:10.1016/j.smim.2006.07.010
   PubMed Web of Science ®Google Scholar
• Woellner C, Gertz EM, Schaffer AA, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424–432 e428. doi:10.1016/j.jaci.2009.10.059
   PubMed Web of Science ®Google Scholar
• Xie YL, Rosen LB, Sereti I, et al. Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNgamma Autoantibodies. Clin Infect Dis. 2016;62(6):770–773. doi:10.1093/cid/civ995
   Web of Science ®Google Scholar
• Yerramilli A, Huang GKL, Griffin DWJ, et al. Disseminated Nontuberculous Mycobacterial Infection Associated With Acquired Immunodeficiency Due to Anti-Interferon gamma Autoantibodies. Open Forum Infect Dis. 2019;6(4):ofz131. doi:10.1093/ofid/ofz131
   Web of Science ®Google Scholar
• Pan M, Qiu Y, Zeng W, Tang S, Wei X, Zhang J. Disseminated Talaromyces marneffei infection presenting as multiple intestinal perforations and diffuse hepatic granulomatous inflammation in an infant with STAT3 mutation: a case report. BMC Infect Dis. 2020;20(1):394. doi:10.1186/s12879-020-05113-4
   Web of Science ®Google Scholar
• Zhang W, Ye J, Qiu C, et al. Rapid and precise diagnosis of T. marneffei pulmonary infection in a HIV-negative patient with autosomal-dominant STAT3 mutation: a case report. Ther Adv Respir Dis. 2020;14:1753466620929225. doi:10.1177/1753466620929225
   Web of Science ®Google Scholar